Cargando…
Perseveration and Choice in Parkinson's Disease: The Impact of Progressive Frontostriatal Dysfunction on Action Decisions
We have previously shown that patients with Parkinson's disease (PD) perseverate in their choice of action relative to healthy controls, and that this is affected by dopaminergic medication (Hughes LE, Barker RA, Owen AM, Rowe JB. 2010. Parkinson's disease and healthy aging: Independent an...
Autores principales: | Hughes, Laura E., Altena, Ellemarije, Barker, Roger A., Rowe, James B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673173/ https://www.ncbi.nlm.nih.gov/pubmed/22661404 http://dx.doi.org/10.1093/cercor/bhs144 |
Ejemplares similares
-
White matter pathology in Parkinson's disease: The effect of imaging protocol differences and relevance to executive function
por: Rae, Charlotte L., et al.
Publicado: (2012) -
Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease
por: Huertas, Ismael, et al.
Publicado: (2017) -
Frontostriatal Cognitive Staging in Parkinson's Disease
por: de la Fuente-Fernández, Raúl
Publicado: (2012) -
The role of frontostriatal impairment in freezing of gait in Parkinson's disease
por: Shine, James M., et al.
Publicado: (2013) -
Frontostriatal Dysfunction During Decision Making in Attention-Deficit/Hyperactivity Disorder and Obsessive-Compulsive Disorder
por: Norman, Luke J., et al.
Publicado: (2018)